학술논문
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
Document Type
Article
Author
Rollot, F.; Casey, R.; Vukusic, S.; Couturier, J.; Wiertlewski, S.; Laplaud, D.-A.; Debouverie, M.; Pelletier, J.; De Sèze, J.; Labauge, P.; Ruet, A.; Thouvenot, E.; Ciron, J.; Berger, E.; Gout, O.; Clavelou, P.; Stankoff, B.; Casez, O.; Bourre, B.; Zephir, H.; Moreau, T.; Lebrun-Frenay, C.; Maillart, E.; Edan, G.; Neau, J.-P.; Montcuquet, A.; Cabre, P.; Camdessanché, J.-P.; Defer, G.; Nasr, H.B.; Maurousset, A.; Hankiewicz, K.; Pottier, C.; Leray, E.
Source
In: Neurotherapeutics . (Neurotherapeutics, March 2022, 19(2):476-490)
Subject
Language
English
ISSN
18787479
19337213
19337213